Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Return on Sales (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Return on Sales for 8 consecutive years, with 0.38% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 3759.0% to 0.38% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.44% through Dec 2025, down 113.0% year-over-year, with the annual reading at 0.03% for FY2025, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 0.38% at Precision Biosciences, up from 1538.62% in the prior quarter.
  • The five-year high for Return on Sales was 0.51% in Q2 2024, with the low at 1538.62% in Q3 2025.
  • Average Return on Sales over 5 years is 176.88%, with a median of 1.13% recorded in 2022.
  • Peak annual rise in Return on Sales hit 3759bps in 2025, while the deepest fall reached -150430bps in 2025.
  • Over 5 years, Return on Sales stood at 4.85% in 2021, then surged by 82bps to 0.85% in 2022, then skyrocketed by 53bps to 0.41% in 2023, then crashed by -9074bps to 37.22% in 2024, then skyrocketed by 101bps to 0.38% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.38%, 1538.62%, and 1173.28% for Q4 2025, Q3 2025, and Q2 2025 respectively.